Sumatriptan succinate and Proventil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan succinate (sumatriptan succinate) and Proventil (albuterol). Common drug interactions include choking among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan succinate and Proventil. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Proventil?

Proventil has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 16,110 Proventil users. Check the latest studies of Proventil.



On Jul, 15, 2026

63 people who take Sumatriptan succinate and Proventil together, and have interactions are studied.

Sumatriptan succinate and Proventil drug interactions.

What are the common drug interactions of Sumatriptan Succinate and Proventil, by gender? *:

female:

  1. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  2. Conjunctivitis (pink eye)
  3. Cystitis (inflammation of the wall of the bladder)
  4. Dermatitis allergic (inflammation of the skin due allergic reaction)
  5. Device expulsion
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Dyspnoea (difficult or laboured respiration)
  8. Encephalopathy (functioning of the brain is affected by some agent or condition)
  9. Fear of disease
  10. Flushing (the warm, red condition of human skin)

male:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Drug abuser
  4. Drug dependence
  5. Drug detoxification
  6. Dyspnoea (difficult or laboured respiration)
  7. Facial pain
  8. Haemoglobin decreased
  9. Headache (pain in head)
  10. Mean platelet volume increased (more than normal average size of platelet cells in blood)

What are the common drug interactions of Sumatriptan Succinate and Proventil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Device expulsion
  2. Implant site haemorrhage (bleeding from implant site)

30-39:

  1. Chest discomfort
  2. Flushing (the warm, red condition of human skin)
  3. Throat tightness

40-49:

  1. Facial pain
  2. Fear of disease
  3. Haemoglobin decreased
  4. Injury
  5. Mean platelet volume increased (more than normal average size of platelet cells in blood)
  6. Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
  7. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  8. Monocyte count increased
  9. Oxygen saturation increased
  10. Pco2 decreased

50-59:

  1. Blood glucose increased
  2. Blood pressure increased
  3. Drug ineffective
  4. Fall
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Hearing impaired
  8. Hospitalisation
  9. International normalised ratio increased
  10. Joint injury

60+:

  1. Sinusitis (inflammation of sinus)
  2. Fungal infection
  3. Rash
  4. Serum ferritin increased
  5. Weight decreased
  6. Weight fluctuation
  7. Back pain
  8. Chronic kidney disease
  9. Dizziness
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 24 people, 38.10%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 25.40%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 14.29%
  4. Pain: 7 people, 11.11%
  5. Drowsiness: 7 people, 11.11%
  6. Wheezing (a high-pitched whistling sound made while you breath): 5 people, 7.94%
  7. Stress And Anxiety: 5 people, 7.94%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and Proventil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan succinate and Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proventil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and albuterol (the active ingredients of Sumatriptan succinate and Proventil, respectively), and Sumatriptan succinate and Proventil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: